A newly approved gene therapy cures blindness — but it costs nearly $1M

The Food and Drug Administration’s approval of Luxturna is the first gene therapy to treat a specific inherited gene mutation, RPE65– and has been deemed a medical milestone. Yet criticism has stirred over the near $ 1 million dollar price tag–making it the most expensive medicine sold in the U.S., ranked by the sticker price.

Full Story Via FOX News

Comments are closed.